Brief: Gentian Diagnostics Q4 EBITDA Loss Narrows To NOK 1.0 Mln
09/02/2024 07:22
Feb 9 (Reuters) - Gentian Diagnostics ASA GENT.OL :
* SALES OF MNOK 37.5 IN 4Q23, UP 34% VERSUS 4Q22 (23%
ORGANIC
GROWTH)
* EBITDA OF NOK -1.0 MILLION IN 4Q23 VERSUS NOK -1.5 MILLION
IN
4Q22
Source text for Eikon: ID:nObiRfJw4a
Further company coverage: GENT.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership
Brief: Gentian Diagnostics Renews Long-Term Partnership With Bühlmann Laboratories
Brief: Gentian Diagnostics Q4 EBITDA NOK 10.5 Million
Brief: Gentian Diagnostics Enters Exclusive Agreement With Global Diagnostics Company